Skip to content

BR DERMATOLOGIE

Active Private limited companyfounded 2023active for 3 yearsKasteeldreef 88, 2970 SchildeKBO/BCE: BE 1001.417.706

Lifetime

3 annual accounts with figures on one time axis
peak of €376,402 in 2025
€376,402▲ 764%
peak of €278,873 in 2025
€278,873▲ 837%
peak of €311,171 in 2025
€311,171▲ 863%
€134,611▲ 15×
Board1 name since 2023
1 director
Documentsfilings and deeds
19-03-2026134 days before the deadline
2025micro format
Gross margin from €43,540 to €376,402Result from €29,777 to €278,873Registered office moved from Berchem to Schilde 24-10Equity from €32,298 to €311,171Debts from €9,138 to €134,611Cash from €40,703 to €156,359

Key points

from the 2025 annual accounts

Equity

€311,171 ▲ 863%

BR DERMATOLOGIE has made a profit in every financial year since 2023.

Result

€278,873 ▲ 837%
€29,8002024€279,0002025

The result rose in 2025 from €29,777 to €278,873.

Turnover

≈ €570,000 estimated

The micro format states no turnover.

Debts

€134,611 ▲ 15×
Taxes and wages
+82,330
Suppliers
+1,519
The rest
+41,625

Debts rose by €125,474 in 2025.

Investments

€52,927 46.9 times depreciation

Green is investment, beige is depreciation.

Position in the sector

€278,873

Higher net result than 94% of companies in human health. The sector median is €59,541, over 21,360 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,332 companies had the same profile as BR DERMATOLOGIE has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,332 companies, not a prediction for BR DERMATOLOGIE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 18-10-2023
  • founderdeed of 23-10-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1001417706
Registered office moved from Berchem to Schilde The registered office moved from Generaal Drubbelstraat 35 te 2600 BERCHEM to Kasteeldreef 88 te 2970 SCHILDE · Board meeting of 01-09-2025 · Gazette deed
Incorporation appointed as director · Founding capital of €2,500, 100 shares · Founded by · published on 23-10-2023 · Gazette deed
First establishment At the time the registered office was still in Berchem, Generaal Drubbelstraat 35.
All 10 events

Comparable companies

same main activity, similar in size and age
Company
BR DERMATOLOGIE Schilde €445,782 €376,402 69.8% -
Dr. Laurens De Ketelaere Ranst €447,508 €345,581 85.9% -
Dr. LVK Mol €503,144 €355,425 96.6% -
Dr. Gilles Uijtterhaegen Bruges €437,818 €375,837 69.9% -
SABIMED Wemmel €511,754 €389,765 79.4% -
DR MIGLIONICO Ganshoren €449,379 €365,018 46.8% -
Tallaert Schoten €466,968 €456,418 95.2% -

These companies have the same main activity as BR DERMATOLOGIE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €438,000 and €512,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 19-10-2023Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.351.662.5552970 Schilde, registered on 19-10-2023
Financial year end
31 December
Peppol
Reachable since 18-11-2025
Company details

Annual accounts 2025

€445,782▲ 976%
Filing
Filed on 19-03-2026, 134 days before the end of the filing period
Financials

Insights on BR DERMATOLOGIE

BR DERMATOLOGIE files the micro format. That format states no turnover. The gross margin rose from €1,933 in 2023 to €376,402 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about BR DERMATOLOGIE

What is the company number of BR DERMATOLOGIE?
The company number of BR DERMATOLOGIE is 1001.417.706. The VAT number is the same number with BE in front: BE 1001.417.706.
Where is BR DERMATOLOGIE based?
The registered office is at Kasteeldreef 88, 2970 Schilde.Company details
What does BR DERMATOLOGIE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of BR DERMATOLOGIE?
BR DERMATOLOGIE is a private limited company (BV).
When was BR DERMATOLOGIE founded?
BR DERMATOLOGIE was founded on 19-10-2023.
Is BR DERMATOLOGIE still active?
Yes, BR DERMATOLOGIE is an active enterprise in the KBO register.
What is the turnover of BR DERMATOLOGIE?
The turnover in financial year 2025 is about €570,000. This figure is estimated from the gross margin of €376,402 and 31 comparable companies (NACE 86220). It probably lies between €500,000 and €790,000.Financials
Is BR DERMATOLOGIE profitable?
In financial year 2025, BR DERMATOLOGIE made a profit of €278,873.
Where can I find the annual accounts of BR DERMATOLOGIE?
BR DERMATOLOGIE filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BR DERMATOLOGIE due?
BR DERMATOLOGIE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.